Company facts
- Headquarters
- Irvine, California
- Most recent report
- 10-Q, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 90 filings
- On EDGAR
- CIK 1778922
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
Financials 3
News 6
Prospectuses and Registrations 4
Ownership 8 of 60
- SCHEDULE 13G Large holder reported a passive stake Feb 17, 2026
- SCHEDULE 13D Large holder reported an active stake Feb 17, 2026
- SCHEDULE 13D Large holder reported an active stake Feb 13, 2026
- SCHEDULE 13D Large holder reported an active stake Feb 13, 2026
- SCHEDULE 13G Large holder reported a passive stake Feb 13, 2026
- 4 Insider reported a trade Feb 11, 2026
- 4/A Insider reported a trade, amended Feb 11, 2026
- 4 Insider reported a trade Feb 11, 2026
Other 8 of 17
- CERT Exchange certified a listing Feb 5, 2026
- 8-A12B Registration of a security for exchange listing Feb 5, 2026
- EFFECT Notice that a registration became effective Jan 30, 2026
- CORRESP Reply to SEC staff Jan 29, 2026
- CORRESP Reply to SEC staff Jan 29, 2026
- CORRESP Reply to SEC staff Jan 29, 2026
- UPLOAD Comment letter from SEC staff Jan 27, 2026
- CORRESP Reply to SEC staff Jan 16, 2026
Everything here comes from SpyGlass Pharma, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.